Apicoaortic valved conduit: Potential for progress?  by Lockowandt, Ulf
A
U
Surgery for Acquired Cardiovascular Disease Lockowandt
7
A
CDpicoaortic valved conduit: Potential for progress?
lf Lockowandt, MD, PhD
O
g
b
s
a
i
M
w
b
b
m
6
R
1
2
t
b
t
w
e
C
v
n
T
p
h
o
a  have
i r-
d
r
o
d the
a
s
s
rFrom the Department of Cardiothoracic
Surgery and Anesthesiology, Karolinska
University Hospital, Stockholm, Sweden.
Supported by grants from the Mats Kleberg
Foundation.
Received for publication March 10, 2006;
revisions received June 24, 2006; accepted
for publication July 7, 2006.
Address for reprints: Ulf Lockowandt, MD,
PhD, Department of Cardiothoracic Sur-
gery and Anesthesiology, Karolinska Uni-
versity Hospital, 171 76 Stockholm, Sweden
(E-mail: ulf.lockowand@karolinska.se).
J Thorac Cardiovasc Surg 2006;132:796-801
0022-5223/$32.00
Copyright © 2006 by The American Asso-
ciation for Thoracic Surgeryp
doi:10.1016/j.jtcvs.2006.07.008
96 The Journal of Thoracic and Cardiobjective: The number of elderly patients who require aortic valve replacement is
rowing, as is the increase of complicating factors, such as previous coronary
ypass grafting and atherosclerotic disease of the ascending aorta. An uncommon
urgical option to aortic valve replacement is the apicoaortic valved conduit. In this
rticle the techniques and outcomes of 13 cases of apicoaortic valved conduit
nsertions in high-risk patients are described.
ethods: From 2002 through 2005, 13 patients (mean age, 75  8.7 years; 8 men)
ith severe calcific aortic stenosis had insertions of an apicoaortic valved conduit
ecause of a porcelain aorta (n  4), previous coronary bypass grafting (n  6), or
oth (n  3). The off-pump technique was used in 9 patients, and a heparinized
iniextracorporeal circulation system was used in 4 patients. Follow-up time was
to 33 months.
esults: Mean intensive care stay was 2  2.7 days, and mean hospital stay was
2  8 days. The 30-day mortality was 15% (2 patients; postoperative days 3 and
8, both caused by myocardial infarction). Mortality later than 30 days postopera-
ively was 23% (3 patients; postoperative day 45 caused by bilateral pulmonary
leeding because of pneumonia, postoperative day 56 caused by myocardial infarc-
ion, and postoperative day 81 caused by pneumonia). The remaining 8 patients
ere doing well, all in New York Heart Association class I or II at follow-up, with
chocardiography showing a low gradient over the valved conduit.
onclusions: The apicoaortic valved conduit in high-risk patients undergoing aortic
alve replacement remains a feasible option, with a substantial potential for tech-
ical development and progress.
he number of elderly patients who require aortic valve replacement (AVR)
is steadily growing. A consequence of this is the increase of complicating
factors, such as previous coronary artery bypass grafting (CABG) with
atent grafts and atherosclerotic disease of the ascending aorta. These risk factors
ave sometimes made conventional AVR an extremely high-risk venture. On
ccasion, the patients have been judged inoperable.
The most consistent risk factor for ascending aortic atherosclerosis is patient
ge.1 One third of patients older than 80 years who undergo cardiac surgery
mportant ascending aortic atherosclerosis.2 Conventional AVR requires both ca
iopulmonary bypass (CPB) and manipulation of the ascending aorta. It has been
eported that atheroembolic events occurred in 37% of patients with severe disease
f the ascending aorta but only in 2% of patients without significant ascending aortic
isease.1 Hypothermic circulatory arrest and different strategies to manage 
scending aorta have been used to improve the results in AVR in patients with a
everely atherosclerotic aorta. Despite these surgical approaches, the postoperative
troke and mortality rates remain high.3,4
In AVR after previous CABG, the main intraoperative problems consist of
e-entry, damage to patent grafts, and difficulty achieving sufficient myocardial
rotection. Several authors report an early mortality in AVR after previous CABG
vascular Surgery ● October 2006
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CDf 17% to 18%.5 The incidence of left internal thora
rtery graft injury varies from 5% to 38%.6,7 In one study
0% of the patients sustained a perioperative myocardial
nfarction as a consequence of left internal thoracic artery
njury.6 There are various options suggested to facili
VR after CABG, including deep hypothermia, beating-
eart procedures, and endovascular techniques. In a system-
tic review of these alternative techniques, it was not pos-
ible to establish the superiority of any procedure over the
thers or whether an overall decrease in mortality could be
chieved.5
The apicoaortic valved conduit (AAVC) avoids re-entry
hrough the sternum, injury to patent grafts, and manipula-
ion of the ascending aorta. The use of an AAVC was first
sed clinically by Sarnoff and colleagues.8 The method ha
ince then been rare, mostly used in pediatric patients9 but
lso in adult patients with stenotic calcified aortic valves in
igh-risk circumstances, such as previous cardiac surgery10
arious studies with a limited number of patients have
emonstrated good long-term results with working hemo-
ynamics.11,12 With the exception of some of the pedia
ABLE 1. Patients’ characteristics with preoperative data
atient age (y) Sex
Severely calcified ascending
aorta
Previous CAB
close to
81 M Y N
79 M Y CABG, 1984
69 M Y CABG, 1977
63 F Y N
57 M N CABG, 1993
82 M N CABG, 1995
61 F N CABG, 1993
77 F N CABG, 1998
77 M N CABG, 1992
75 M N CABG, 1997
83 M Y CABG, 1994
84 F Y N
81 F Y N
ABG, Coronary artery bypass grafting; NYHA, New York Heart Associa
Abbreviations and Acronyms
AAVC apicoaortic valved conduit
AVR  aortic valve replacement
CABG coronary artery bypass grafting
CPB  cardiopulmonary bypassyocardial infarction; F, female.
The Journal of Thoracicases, these operations have been performed with CPB. In
ddition, Vassiliades13 has described a technique for o
ump AAVC insertion in 3 adult patients.
The objective of this article is to evaluate different tech-
iques and the outcome of 13 cases of AAVC insertions in
igh-risk and often elderly patients with stenotic aortic
alves. Of these procedures, 9 were performed off pump,
hich, to our knowledge, is the largest series to date re-
orted of this technique. Four operations were performed
ith a heparinized miniextracorporeal circulation system.
ethods
his study was approved by the Ethics Committee of the Karolin-
ka Hospital, and the patients were operated on after informed
onsent. If not otherwise stated, all data are presented as means 
tandard deviations.
Thirteen patients (mean age, 75 8.7 years; 8 men) underwent
nsertions of AAVCs from 2002 through 2005. All patients had
evere calcific aortic stenosis, and all were in New York Heart
ssociation class III or IV. The mean pressure gradient was 52 
7 mm Hg, with a mean aortic orifice area of 0.63  0.15 cm2. All
ut 3 patients had a good left ventricular function, with an ejection
raction of 55% or more. Two patients had a left ventricular
jection fraction of 30%, and 1 had an ejection fraction of 25%.
nly one of the patients (ejection fraction of 30%) had a dilated
eft ventricle, with an end-diastolic diameter of 54 mm. All pa-
ients had dyspnea, 2 had episodes of pulmonary edema, and 3 had
clinical presentation with frank syncope. Two patients had been
enied surgical intervention at other institutions, and 1 had under-
one sternotomy at another hospital, was found to be inoperable,
nd then underwent chest closure. A porcelain aorta was present in
results
ith patent graft/grafts
side of sternum Other major risk factors
Poor LV, severe extracardiac arteriopathy
Poor LV, severe extracardiac arteriopathy
G, 1992 Severe extracardiac arteriopathy, chronic
pulmonary disease
Poor dilated LV function, severe
extracardiac arteriopathy, severe
diabetes, cerebral lymphoma
Poor nutritional state
Severe extra cardiac arteriopathy,
preoperative kidney failure
Severe extracardiac arteriopathy
M, Male; Poor LV, left ventricular ejection fraction of 30% or less; MI,and
G w
back
; CAB
tion;and Cardiovascular Surgery ● Volume 132, Number 4 797
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CDcases, 6 had previous coronary bypass grafting, and 3 had both.
or further patient characteristics, see Table 1.
In addition to routine preoperative investigations, such as cor-
nary angiography and echocardiography, computed tomography
f the descending aorta was carried out to asses the possibility of
erforming the distal anastomosis of the conduit because severe
theroma of the descending aorta makes the procedure inadvisable.
urthermore, also regarded as contraindications were an aortic
egurgitation of greater than I to II/IV and thrombus material in the
eft ventricular apex.
The off-pump technique was used in 9 patients, and a heparin-
zed miniextracorporeal circulation system was used in 4 patients.
nesthesia was induced, and intubation was performed with a
ouble-lumen endotracheal tube for single-lung ventilation. Hep-
rin at a dose of 150 U/kg was administered in the off-pump group,
s well as in the operations including a heparinized miniextracor-
oreal circulation system. A cell saver (Electa; Dideco, Sorin
roup, Modena, Italy) was used. Access to the descending aorta
nd the apex of the heart was obtained by performing a low
horacotomy through the sixth intercostal space. The left lung was
eflated, the pulmonary ligament was divided between the 2 lig-
tures, and the left lung was mobilized cranially to ensure access
o the aorta. A partial occluding clamp was applied after the pleura
as incised over the distal descending aorta. The distal end of the
alved conduit (Hancock Bioprosthetic Valved Conduit, 22 mm;
edtronic, Minneapolis, Minn) was attached to the aorta with a
-0 nonabsorbable suture. By opening the pericardium and fixating
t to the chest wall, an excellent exposure of the apex was
chieved. The apex of the left ventricle was investigated with an
chocardiographic probe (Acuson AV5, Acuson Sequoia C512;
iemens Medical Solutions Malvern, Pa) to avoid thin scarred
yocardium and thrombus material and to keep clear of the
ABLE 1. Continued
Symptoms other than
dyspnea (NYHA III)
Interrupted operation at other institution
because of porcelain aorta
ngina N
N
N
Y
N
ngina N
ulmonary edema N
yncope N
N
ngina N
yncope N
ulmonary edema N
yncope N98 The Journal of Thoracic and Cardiovascular Surgery ● Octoeptum and papillary muscles. The echocardiographic investiga-
ion did not change the approach from off pump to on pump in any
f the cases. By using a surgical marker, the circumference and
ntended position of a Hancock Apical Left Ventricular Connector
22 mm; Medtronic) was marked on the apex. The position was
hosen slightly anterior and lateral to the apex, keeping some
istance to the distal end of the left anterior descending artery. The
nd of the connector is rigid and angled 90°, which makes it easy
o attach to the valved conduit in a later stage. Taking great care,
he circumference of the intended position was then encircled with
eep muscular bites entering and exiting the epicardium with
legeted 2-0 Ethibond sutures on atraumatic V-7 or MH needles
Ethicon Inc, Norderstedt, Germany). The mattress sutures were
assed through the collar of the connector, and the connector was
owered toward the heart. The sutures were kept aside to expose
he apex. A stab wound was performed, the bleeding was digitally
ontrolled, and the tip of the coring device (Hancock Model
701A, Trocar Blade, 22 mm; Medtronic) was pushed into the left
entricle. By using the trocar blade, a core of ventricular muscle
as removed, and the connector was quickly slid into place. The
nterrupted sutures were securely tied. With a running 3-0 nonab-
orbable suture, the distal end of the apical connector was attached
o the valved conduit, and the graft was deaired. Finally, FloSeal
Baxter International Inc, Deerfield, Ill) was applied to all suture
ines. The conduit was straightforwardly positioned without kink-
ng, following the lateral aspect of the pericardium medial to the
eft lower lobe. Tubes for drainage were placed, and the chest was
losed.
Four patients were circulatory supported with a heparinized
iniextracorporeal circulation system (AFFINITY NT Oxygen-
tor, Carmeda BioActive Surface, Bio-Pump Plus Centrifugal
lood Pump; Medtronic). The right femoral vein was used for
enied operation at
other institution Results
Y Died day 28 of MI
N Well at 33 mo
N Well at 31 mo
N Well at 20 mo
N Well at 12 mo
Y Died day 56 of MI
N Well at 10 mo
N Well at 10 mo
N Well at 9 mo
N Reoperation day 53 because of infection,
died day 81 of pneumonia
N Died day 3 of MI
N Died day 45 of pneumonia
N Well at 6 moDber 2006
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A
CDenous access, and the right femoral artery (in one case the graft
ttached to the descending aorta) was used for arterial access. The
xtracorporeal system was complemented with a cell saver (Electa,
ideco). The extracorporeal system was started at the beginning of
he manipulation of the left ventricular apex and terminated when
ow was established in the conduit.
Follow-up was performed during outpatient visits, including
hest radiography and echocardiography, at 3, 6 and 12 months
nd then yearly. The anticoagulation regimen for all patients was
months of warfarin. Follow-up time was 6 to 33 months.
esults
ean intensive care unit stay was 2  2.7 days, and mean
ospital stay was 12  8 days. Mean operation time was
08 64 minutes, and mean bypass time (in 4 patients) was
8  13 minutes. Mean perioperative bleeding was 3060 
700 mL (off-pump, 2440  933 mL; on-pump, 4450 
197 mL), and mean postoperative bleeding was 812 
20 mL (off-pump, 747 371 mL; on-pump, 957 483 mL).
In-hospital mortality was 8%. One patient died on day 3
f a myocardial infarction, which was diagnosed at autopsy.
n-house major complications were 31% (4 patients), in-
luding one case of kidney failure in a patient with known
reoperative kidney failure (the postoperative failure did not
equire dialysis but did require a prolonged stay in the
ntensive care unit of 11 days). There were also 2 cases of
eoperation because of bleeding, and in none of the cases
ould a bleeding point from the conduit or from the attach-
ent of the conduit to the left ventricular apex or the
escending aorta be found. There was one case of postop-
rative hyponatremia of unknown cause. The condition was
ifficult to treat and resulted in a prolonged hospital stay of
4 days. The patient was well at discharge, and at follow-up
months postoperatively, the patient had no deficits of
odium. Six patients had benign, self-terminating ventricu-
ar arrhythmias on the first postoperative days.
Postdischarge mortality was 30% (4 patients). One pa-
ient died on day 28 of a myocardial infarction that caused
partial dehiscence of the conduit from the left ventricular
pex and a subsequent bleed. The cause of death was
stablished with a postmortem examination. One patient
ied on day 45 of bilateral pulmonary bleeding because of
neumonia, and the postmortem examination showed an
ntact conduit. One patient died on day 56 of a myocardial
nfarction diagnosed on the basis of electrocardiography,
nzymes, and clinical presentation. No autopsy was per-
ormed. There was 1 death on day 81 of pneumonia, and
utopsy showed an intact conduit. This patient had been read-
itted on day 53 with signs of infection and dyspnea. Inves-
igations revealed a dehiscence of the conduit from the left
entricular apex, with adhesions creating a false aneurysm-
ike condition. At reoperation, the cause of the dehiscence
as found to be an infectious process, with frank pus aroundhe proximal part of the conduit close to the heart. The i
The Journal of Thoraciconduit could be reattached to the heart and wrapped with a
ap of omentum. The patient was discharged on day 8 and
as well with a normalized blood count.
Mean postoperative time of echocardiography evaluation
as 16.4  9.8 months. Left ventricular function did not
hange after the operation. The good left ventricular func-
ion preoperatively remained good. The 3 patients display-
ng reduced left ventricular ejection fraction continued do-
ng so at follow-up. There was no reduction in end-diastolic
iameter in the only patient with a left ventricular dilatation.
o relation could be detected between preoperative ventric-
lar function and mortality. Postoperatively, only 1 patient
ad a small antegrade flow through the native valve; the
ther 12 had none or a hardly detectable antegrade flow
hrough the stenosed valve. The pressure gradient across the
alved conduit was difficult to estimate. However, the flow
elocity was low, 1.4 0.3 m/s, corresponding to a gradient
f about 5 mm Hg. At follow-up, the surviving patients
ere doing excellent, and all were in New York Heart
ssociation class I or II. There were no known thrombo-
mbolic events. For results, also see Table 1.
iscussion
espite suggested modifications of conventional surgical in-
ervention in AVR after CABG or in the presence of a severely
alcified ascending aorta, mortality remains high.3-5 Some of
hese surgical adjustments, such as deep hypothermic arrest
nd replacement of the ascending aorta, add complexity and
isk on their own to these often elderly and fragile patients.
n this setting the search for methods improving the results
ontinues to be a justifiable undertaking.
The most commonly used method for AAVC placement
s using CPB either in the arrested or fibrillating heart.
xcept for some single case reports, there are only 2 articles
escribing a more systematic approach to an off-pump
echnique. Khanna and coworkers9 operated on 6 childre
ff pump, and Vassiliades13 used a refined procedure in
dult patients. By inserting the AAVC off pump, the detri-
ental effects of both CPB and global cardiac ischemia are
voided. Several long-term follow-ups have demonstrated
hat the AAVC insertion effectively lessens the left
entricular–aortic pressure gradient, improves ventricular
unction, and maintains normal systemic blood flow.11,12,14
Challenging in the operations presented in this article
as the intraoperative bleeding, which did not decrease with
xperience. The key moment of blood loss was at the time
f the coring and the securing of the connector to the
yocardium, making a stand-by for rapid transfusion fairly
nproblematic. Possibly the blood loss during the securing
ould be reduced with a smaller coring device, but on the
ther hand, the insertion would most likely become more
emanding. The heart was arrested in 1 patient by admin-
stering a rapid intravenous infusion of 6 mg of adenosine to
and Cardiovascular Surgery ● Volume 132, Number 4 799
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A
CDimplify the insertion. However, in this patient the heart
estarted with considerable difficulty after the substantial
lood loss and with the connector not yet attached to the
raft (ie, without afterload reduction). When using this
pproach or rapid ventricular pacing, the connector has to be
ttached to the graft before the insertion of the connector
nto the apex to achieve swift afterload reduction.
A heparinized miniextracorporeal circulation system was
sed in the last 4 patients to increase surgeon comfort and to
ake potential complications more controllable. In this
roup the bleeding was not reduced, but the systemic cir-
ulation was better controlled throughout the phase of in-
ertion and attachment of the connector.
This is an observational clinical report, including 2 dif-
erent techniques of a surgical method continuously gener-
ting experience back to the surgical team throughout the
tudy. There is no control group. The possibility to deter-
ine the superiority of one surgical technique over another
s thereby limited. However, it is probably not erroneous to
laim that the off-pump technique is presumably less trau-
atic to these frail patients, whereas the on-pump procedure
rovides greater security should something go wrong.
There are potentials for developing the attachment of the
onduit to the apex, making it a reproducible, safer, and less
loody part of the operation, either on or off pump. One
ption is the attractive Seldinger-like technique described
y Vassiliades.13 A further technique currently developed
ur unit consists of a sewing ring secured to the left ven-
ricular apex before removing a myocardial core of the left
entricular apex. The conduit is then inserted into the left
entricular cavity and secured to the ring. This method is
imilar to that used when deploying a Jarvik left ventricular
ssist device.15
There were no perioperative deaths in either group, but
here were 5 (38%) deaths in 90 days. This small material
akes it unfeasible to draw any certain conclusions about
atient selection. However, it is notable that the patients not
urviving 90 days included some of the oldest patients, with
mean age of 81  3.2 years compared with a mean age of
5  8.7 years for the entire group.
Three patients succumbed to a myocardial infarction
ostoperatively. They all had known coronary artery dis-
ase. Experimental works regarding the placement of the
istal anastomoses of left ventricular assist devices have
hown that an attachment of the pump with pulsative flow to
he descending aorta is associated with increased flow stag-
ation in the ascending aorta.16,17 In the patients presente
n this article, no more than one had a residual, small
ntegrade flow through the stenosed native aortic valve, and
n the remaining 12 patients, there was hardly any antegrade
ow through the native valve, making a contribution to the
oronary flow this way implausible. Until further investiga-
ions show otherwise, patients with coronary artery disease
1
00 The Journal of Thoracic and Cardiovascular Surgery ● Octohould perhaps only be accepted with caution for AAVC
nsertion.
In conclusion, the majority of patients were doing fine at
ollow-up. Complications, such as postoperative bleeding,
nfection, and benign arrhythmias, were manageable. The
0-day mortality of 38% is notable but not entirely unex-
ected among these sometimes very elderly and weak pa-
ients. Autopsies did not show malfunctioning of any of the
onduits. The AAVC, using either an off-pump technique or
heparinized miniextracorporeal circulation system in high-
isk patients undergoing AVR, is therefore a feasible alter-
ative to conventional surgical intervention that is cau-
iously used in patients with coronary artery disease.
urthermore, the potential for technical development and
rogress in this method is substantial.
I acknowledge the great skills of Jan Liska, MD, Department of
ardiothoracic Surgery and Anesthesiology, Karolinska Univer-
ity Hospital, for being of utmost importance in developing the
urgical techniques presented.
eferences
1. Blauth CI, Cosgrove DM, Webb BW, Ratliff NB, Boylan M, Pied-
monte MR, et al. Atheroembolism from the ascending aorta. An
emerging problem in cardiac surgery. J Thorac Cardiovasc Surg.
1992;103:1104-11.
2. Davila-Roman VG, Murphy SF, Nickerson NJ, Kouchoukos NT,
Schechtman KB, Barzilai B. Atherosclerosis of the ascending aorta is
an independent predictor of long-term neurologic events and mortality.
J Am Coll Cardiol. 1999;33:1308-16.
3. Kouchoukos NT, Wareing TH, Daily BB, Murphy SF. Management of
the severely atherosclerotic aorta during cardiac operations. J Card
Surg. 1994;9:490-4.
4. Gillinov AM, Lytle BW, Hoang V, Cosgrove DM, Banbury MK,
McCarthy PM, et al. The atherosclerotic aorta at aortic valve replace-
ment: surgical strategies and results. J Thorac Cardiovasc Surg. 2000;
120:957-63.
5. Shanmugam G. Aortic valve replacement following previous coronary
surgery. Eur J Cardiothorac Surg. 2005;28:731-5.
6. Gillinov AM, Casselman FP, Lytle BW, Blackstone EH, Parsons EM,
Loop FD, et al. Injury to a patent left internal thoracic artery graft at
coronary reoperation. Ann Thorac Surg. 1999;67:382-6.
7. Ivert T, Ekestrom S, Peterffy A, Welti R. Coronary artery reoperations.
Early and late results in 101 patients. Scand J Thorac Cardiovasc Surg.
1988;22:111-8.
8. Sarnoff SJ, Donovan TJ, Case RB. The surgical relief of aortic stenosis
by means of apical-aortic valvular anastomosis. Circulation. 1955;11:
564-74.
9. Khanna SK, Anstadt MP, Bhimji S, Bannan MM, Mawulawde K,
Zumbro GL, et al. Apico-aortic conduits in children with severe left
ventricular outflow tract obstruction. Ann Thorac Surg. 2002;73:81-6.
0. Cooley DA, Lopez RM, Absi TS. Apicoaortic conduit for left ventric-
ular outflow tract obstruction: revisited. Ann Thorac Surg. 2000;69:
1511-4.
1. Nihill MR, Cooley DA, Norman JC, Hallman GL, McNamara DG.
Hemodynamic observations in patients with left ventricle to aorta
conduit. Am J Cardiol. 1980;45:573-82.
2. Fogel MA, Rychik J, Chin AJ, Hubbard A, Weinberg PM. Evaluation
and follow-up of patients with left ventricular apical to aortic conduits
with 2D and 3D magnetic resonance imaging and Doppler echocardi-
ography: a new look at an old operation. Am Heart J. 2001;141:630-6.3. Vassiliades T. Off-pump apicoaortic conduit insertion for high-risk
patients with aortic stenosis. Eur J Cardiothorac Surg. 2003;23:156-8.
ber 2006
11
1
1
Lockowandt Surgery for Acquired Cardiovascular Disease4. Renzulli A, Gregorio R, De Feo M, Ismeno G, Covino FE, Cotrufo M.
Long-term results of apico-aortic valved conduit for severe idiopathic
hypertrophic subaortic stenosis. Tex Heart Inst J. 2000;27:24-8.
5. Siegenthaler MP, Martin J, Frazier OH, Beyersdorf F. Implantation of
the permanent Jarvik-2000 left-ventricular-assist-device: surgical tech-
nique. Eur J Cardiothorac Surg. 2002;21:546-8.
The Journal of Thoracic6. Litwak KN, Koenig SC, Tsukui H, Kihara S, Wu Z, Pantalos GM.
Effects of left ventricular assist device support and outflow graft
location upon aortic blood flow. ASAIO J. 2004;50:432-7.
7. DiGiorgi PL, Smith DL, Naka Y, Oz MC. In vitro characterization of
aortic retrograde and antegrade flow from pulsatile and non-pulsatile
ventricular assist devices. J Heart Lung Transplant. 2004;23:186-92.
and Cardiovascular Surgery ● Volume 132, Number 4 801
A
CD
